Role of Surgery in Small Cell Lung Cancer

Surgical Oncology Clinics of North America

Volumn 20, Issue 4, 2011, Pages 769-777

  Goldstein, Seth D ^a   Yang, Stephen C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lung cancer; Small cell; Surgery

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; PACLITAXEL; PLATINUM DERIVATIVE; VINCRISTINE;

CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; DOSIMETRY; HISTOPATHOLOGY; HUMAN; LUNG RESECTION; LUNG SMALL CELL CANCER; MULTICENTER STUDY (TOPIC); MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURVIVAL RATE; SURVIVAL TIME;

HUMANS; LUNG NEOPLASMS; PROGNOSIS; SMALL CELL LUNG CARCINOMA;

EID: 80053904666     PISSN: 10553207     EISSN: 15585042     Source Type: Journal    
DOI: 10.1016/j.soc.2011.08.001     Document Type: Review

References (35)

1. Govindan R., Page N., Morgensztern D., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006, 24:4539-4544.
2. Jänne P.A., Freidlin B., Saxman S., et al. Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America: meaningful improvements in survival. Cancer 2002, 95:1528-1538.
3. Stahel R.A., Ginsberg R., Havemann K., et al. Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer 1989, 5:119-126.
4. Micke P., Faldum A., Metz T., et al. Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer-what limits limited disease?. Lung Cancer 2002, 37:271-276.
5. Shepherd F.A., Ginsberg R.J., Haddad R., et al. Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. J Clin Oncol 1993, 11:1592-1597.
6. Fujimori K., Yokoyama A., Kurita Y., et al. A pilot phase 2 study of surgical treatment after induction chemotherapy for resectable stage I to IIIA small cell lung cancer. Chest 1997, 111:1089-1093.
7. Rea F., Callegaro D., Favaretto A., et al. Long term results of surgery and chemotherapy in small cell lung cancer. Eur J Cardiothorac Surg 1998, 14:398-402.
8. Eberhardt W., Korfee S. New approaches for small-cell lung cancer: local treatments. Cancer Control 2003, 10:289-296.
9. Rostad H., Naalsund A., Jacobsen R., et al. Small cell lung cancer in Norway. Should more patients have been offered surgical therapy?. Eur J Cardiothorac Surg 2004, 26:782-786.
10. Badzio A., Kurowski K., Karnicka-Mlodkowska H., et al. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer. Eur J Cardiothorac Surg 2004, 26:183-188.
11. Brock M.V., Hooker C.M., Syphard J.E., et al. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: its time has come. J Thorac Cardiovasc Surg 2005, 129:64-72.
12. Tsuchiya R., Suzuki K., Ichinose Y., et al. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg 2005, 129:977-983.
13. Granetzny A., Boseila A., Wagner W., et al. Surgery in the tri-modality treatment of small cell lung cancer. Stage-dependent survival. Eur J Cardiothorac Surg 2006, 30:212-216.
14. Bischof M., Debus J., Herfarth K., et al. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy. Strahlenther Onkol 2007, 183:679-684.
15. Lim E., Belcher E., Yap Y.K., et al. The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate. J Thorac Oncol 2008, 3:1267-1271.
16. Lee C.B., Morris D.E., Fried D.B., et al. Current and evolving treatment options for limited stage small cell lung cancer. Curr Opin Oncol 2006, 18:162-172.
17. Miller A.B., Fox W., Tall R. Five-year follow-up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus. Lancet 1969, 2:501-505.
18. Fox W., Scadding J.G. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small celled or oat celled carcinoma of bronchus. Ten year follow up. Lancet 1973, 2:63-65.
19. Shields T.W., Higgins G.A., Matthews M.J., et al. Surgical resection in the management of small cell carcinoma of the lung. J Thorac Cardiovasc Surg 1982, 84:481-488.
20. Lad T., Piantadosi S., Thomas P., et al. A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy. Chest 1994, 106:320S-323S.
21. Turrisi A.T., Kim K., Blum R., et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999, 340:265-271.
22. Schild S.E., Bonner J.A., Shanahan T.G., et al. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004, 59:943-951.
23. Asamura H., Kameya T., Matsuno Y., et al. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 2006, 24:70-76.
24. Shepherd F.A., Ginsberg R., Patterson G.A., et al. Is there ever a role for salvage operations in limited small-cell lung cancer?. J Thorac Cardiovasc Surg 1991, 101:196-200.
25. Smythe W.R., Estrera A.L., Swisher S.G., et al. Surgical resection of non-small cell carcinoma after treatment for small cell carcinoma. Ann Thorac Surg 2001, 71:962-966.
26. Yu J.B., Decker R.H., Detterbeck F.C., et al. Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol 2010, 5:215-219.
27. Schreiber D., Rineer J., Weedon J., et al. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?. Cancer 2010, 116:1350-1357.
28. Eberhardt W., Stamatis G., Stuschke M., et al. Prognostically orientated multimodality treatment including surgery for selected patients of small cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial. Br J Cancer 1999, 81:1206-1212.
29. Inoue M., Nakagawa K., Fujiwara K., et al. Results of preoperative mediastinoscopy for small cell lung cancer. Ann Thorac Surg 2000, 70:1620-1623.
30. Wada H., Yokomise H., Tanaka F., et al. Surgical treatment of small cell carcinoma of the lung: advantage of preoperative chemotherapy. Lung Cancer 1995, 13:45-56.
31. Simon G.R., Turrisi A. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:324S-339S.
32. Anraku M., Waddell T.K. Surgery for small-cell lung cancer. Semin Thorac Cardiovasc Surg 2006, 18:211-216.
33. Koletsis E.N., Prokakis C., Karanikolas M., et al. Current role of surgery in small cell lung carcinoma. J Cardiothorac Surg 2009, 4:30.
34. Blackhall F.H., Shepherd F.A. Small cell lung cancer and targeted therapies. Curr Opin Oncol 2007, 19:103-108.
35. Vallières E., Shepherd F.A., Crowley J., et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009, 4(9):1049-1059.